OR WAIT null SECS
June 07, 2024
Causal mediation analysis sought to determine how public hesitancy plays a role in the government procurement of certain vaccines.
In an interview with Pharma Commerce Editor Nicholas Saraceno, Lung-I Cheng, PhD, VP, Head of Cell & Gene Therapy Service Line, Cencora, offers his thoughts on industry pain points and where he envisions the market progressing in terms of its technological capabilities.
June 06, 2024
Ashfield Event Experiences and WRG merge in an effort to better serve the healthcare industry.
If Congress doesn't act soon, it could result in more health inequities.
An analysis of the general medicine portion of the pharmacy market amid ensuing challenges.
June 05, 2024
The development and manufacturing plant will be constructed in Texas, and is expected to become operational by Q1 2025.
The courts reversed certain key guidance documents issued by the Health Resources and Services Administration for the 340B Program, which raises uncertainty.
June 04, 2024
The new plant in Italy is expected to tackle the rise in biopharmaceutical material demand, specifically for GLP-1s.
A retrospective study explores the connection between adherence and racial/ethnic disparities among patients with Alzheimer’s disease, along with similar dementias.
June 03, 2024
The Netherlands plant is expected to provide solutions that can help further the development of advanced therapies.